- A -

- B -

- D -

- F -

- G -

- I -

- N -

- P -

- S -

- U -

The following additional reports are available if your subscriptions cover a complete category.

European pharmaceutical regulation

Published 01/03/2004
A unique report that succinctly outlines the major issues currently affecting pharmaceutical companies and the industry regulators.
View full details »

Parallel trade in pharmaceuticals

Published 01/10/2003
A 60,000 word strategic publication providing valuable market overview and essential data to the conduct of sound business policies.
View full details »

Trends in international pharmaceutical pricing and reimbursement

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

The global AIDS crisis and drug pricing controversy

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

The future of parallel trade in pharmaceuticals in Europe

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Schering's policy of pharmaceutical price harmonisation in Europe

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

What does the decision on the GSK case in Spain signify for differential pricing in Europe

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Bio-pharmaceutical Prices and the Effects on the U.S. Economy

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Hospital negotiation - the use of health economics as a support for new product pricing

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Pricing considerations for new products in Europe

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Managing price throughout the life cycle of a pharmaceutical product

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

The art of pricing in the pharmaceutical industry

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

The importance of health economics in achieving a sustainable price for reimbursement

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Global pricing strategies for pharmaceutical product launches

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Integrating pricing and reimbursement needs into drug development

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Assessing the pharmaceutical price modelling tools

Published 01/03/2003
An excerpt from The Pharmaceutical Pricing Compendium - a practical guide to the pricing and reimbursement of medicines.
View full details »

Health economics in the drug life cycle

Published 01/01/2003
A unique report showing how health economics can create substantial added-value, as well as provide the basis for early decisions to continue or abandon product development.
View full details »

EU accession by Central & Eastern European countries

Published 10/10/2000
A report documenting the changes, threats or opportunities, enlargement brings to multinationals in the pharmaceutical sector.
View full details »